GeneOne Life Science, Inc.
011000.KS
Price:
$2000
Market Cap:
$169.71B
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company also develops GLS-3000 and GLS-5310 for the treatment of SARS-CoV-2; GLS-5100 to treat VZV-Shingles; and GLS-5140 for the treatment of SFTS. In addition, it is developing GLS-5300, which is in Phase II clinical trial for MERS; GLS-5700 that is in Phase I clinical trial for ...[Read more]
Industry
Biotechnology
IPO Date
2000-02-04
Stock Exchange
KSC
Ticker
011000.KS
PE Ratio
[-2.95]
ROE
[-64.58%]
Current Ratio
[0.57]
Dividend Yield
[0%]
Enterprise Value
[194.84B]
Dividend History
The ROE as of December 2025 (TTM) for GeneOne Life Science, Inc. (011000.KS) is -64.58%
According to GeneOne Life Science, Inc.’s latest financial reports and current stock price. The company's current ROE is -64.58%. This represents a change of 288.37% compared to the average of -16.63% of the last 4 quarters.
GeneOne Life Science, Inc. (011000.KS) Historical ROE (quarterly & annually)
How has 011000.KS ROE performed in the past?
The mean historical ROE of GeneOne Life Science, Inc. over the last ten years is -35.11%. The current -64.58% ROE has changed 83.94% with respect to the historical average. Over the past ten years (40 quarters), 011000.KS's ROE was at its highest in in the September 2015 quarter at 8.87%. The ROE was at its lowest in in the December 2023 quarter at -35.70%.
Average
-35.11%
Median
-36.06%
Minimum
-69.75%
Maximum
3.58%
GeneOne Life Science, Inc. (011000.KS) ROE by Quarter and Year
Discovering the peaks and valleys of GeneOne Life Science, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 231.80%
Maximum Annual ROE = 3.58%
Minimum Annual Increase = -1313.74%
Minimum Annual ROE = -69.75%
| Year | ROE | Change |
|---|---|---|
| 2024 | -56.70% | -18.72% |
| 2023 | -69.75% | 231.80% |
| 2022 | -21.02% | 172.16% |
| 2021 | -7.72% | -59.20% |
| 2020 | -18.93% | -40.21% |
| 2019 | -31.66% | -21.73% |
| 2018 | -40.45% | -37.71% |
| 2017 | -64.94% | 49.26% |
| 2016 | -43.51% | -1313.74% |
| 2015 | 3.58% | -119.18% |
GeneOne Life Science, Inc. (011000.KS) Average ROE
How has 011000.KS ROE performed in the past?
The current ROE of GeneOne Life Science, Inc. (011000.KS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-49.16%
5-year avg
-34.83%
10-year avg
-35.11%
GeneOne Life Science, Inc. (011000.KS) ROE vs. Peers
How is 011000.KS’s ROE compared to its peers?
GeneOne Life Science, Inc.’s ROE is less than Macrogen, Inc. (-0.45%), less than EASY BIO,Inc. (25.51%), greater than Genexine, Inc. (-15.25%), greater than Amicogen, Inc. (-37.49%), greater than IMBdx (-26.83%), greater than JETEMA, Co., Ltd. (-6.45%), greater than MedPacto, Inc. (-27.34%), greater than Encell Co. Ltd. (-42.17%), greater than Anterogen.Co.,Ltd. (-1.98%), greater than HLB Therapeutics Co.,Ltd. (-5.25%),
| Company | ROE | Market cap |
|---|---|---|
| -0.45% | $203.71B | |
| 25.51% | $203.45B | |
| -15.25% | $219.89B | |
| -37.49% | $107.26B | |
| -26.83% | $144.38B | |
| -6.45% | $228.42B | |
| -27.34% | $223.47B | |
| -42.17% | $213.89B | |
| -1.98% | $404.75B | |
| -5.25% | $236.34B |
Build a custom stock screener for GeneOne Life Science, Inc. (011000.KS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneOne Life Science, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
GeneOne Life Science, Inc. (011000.KS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like GeneOne Life Science, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is GeneOne Life Science, Inc.'s ROE?
How is the ROE calculated for GeneOne Life Science, Inc. (011000.KS)?
What is the highest ROE for GeneOne Life Science, Inc. (011000.KS)?
What is the 3-year average ROE for GeneOne Life Science, Inc. (011000.KS)?
What is the 5-year average ROE for GeneOne Life Science, Inc. (011000.KS)?
How does the current ROE for GeneOne Life Science, Inc. (011000.KS) compare to its historical average?